Further, previous studies have demonstrated that CXCR4 was highly expressed in pancreatic cancer, and the elevated levels of SDF-1 and CXCR4 were associated with poor prognosis (Wehler et al., 2006; Liang et al., 2010). The gene discussed is CXCR4; the disease is familial pancreatic carcinoma.